Literature DB >> 23133010

Management of hemorrhage of retro hepatic inferior vena cava injury during piggy-back technique for liver transplantation.

Aydin Unal1, Yazici Pinar, Zeytunlu Murat, Kilic Murat.   

Abstract

BACKGROUND: Injury to large abdominal vessels is still one of the most terrifying results of trauma or intraoperative faults, as the management of the hemorrhage is hardly difficult due to being torrentially and unaware of the proper reparation. The controversial problem is which technique should be preferred in case of injury to RHIVC and how can it be managed with minimal risk. PATIENTS AND METHODS: Over two-year period, we retrospectively analyzed the patients who had undergone adult-to-adult liver transplantation and collected data about the injuries to RHIVC during recipient hepatectomy. All patients were treated with the same surgical technique including digital compression and continuous suturing the tear.
RESULTS: Twenty five patients (21 male, 4 female) were detected. The causative factors for end stage liver disease included hepatitis B, hepatitis C with or without hepatocellular carcinoma, autoimmune hepatitis, alcoholic hepatitis, cryptogenic hepatitis, Wilson disease, and nonalcoholic steatohepatitis. Mean diameter of the injury was measured 0.5 cm (range: 0.2-1.6). Only three patients (12%) had more than one injury. Mean amount of blood loss between injury and repair was 130 cc (40-350 cc). There was no operative mortality.
CONCLUSION: Calmness of the operative team followed by the appropriate surgical approach is the key of the success in case of any injury to RHIVC. Digital compression technique can be enough to prevent massive bleeding and repair the injury tract without any vascular exclusion that may result with serious postoperative complications. We proposed this technique because of its ability by most surgeon and easy to perform in a safe way.

Entities:  

Keywords:  Approach to vena cava injury; Digital compression; Retrohepatic inferior vena cava; Surgical technique

Year:  2008        PMID: 23133010      PMCID: PMC3452594          DOI: 10.1007/s12262-008-0004-1

Source DB:  PubMed          Journal:  Indian J Surg        ISSN: 0973-9793            Impact factor:   0.656


  9 in total

1.  Total vascular exclusion for liver resection.

Authors:  C Huguet; A Gavelli
Journal:  Hepatogastroenterology       Date:  1998 Mar-Apr

2.  Total vascular exclusion of the liver for the resection of lesions in contact with the vena cava or the hepatic veins.

Authors:  T Berney; G Mentha; P Morel
Journal:  Br J Surg       Date:  1998-04       Impact factor: 6.939

3.  Gross anatomy of the retrohepatic segment of the inferior vena cava in northwest Indians.

Authors:  Daisy Sahni; Y K Chawla
Journal:  Indian J Med Res       Date:  2006-07       Impact factor: 2.375

4.  [Injury of inferior vena cava].

Authors:  A A Baeshko; V V Klimovich; M T Voevoda; Iu N Orlovskiĭ; P V Gornostaĭ; V A Iushkevich
Journal:  Khirurgiia (Mosk)       Date:  2006

5.  The use of hypothermia and circulatory arrest to control intraoperative bleeding from the inferior vena cava.

Authors:  N A Habib; N E Michail; P Smith
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

6.  Major hepatic resection under total vascular exclusion.

Authors:  H Bismuth; D Castaing; O J Garden
Journal:  Ann Surg       Date:  1989-07       Impact factor: 12.969

7.  Intermittent complete vascular exclusion of the liver during hepatectomy: technique and indications.

Authors:  D Elias; P Dubé; S Bonvalot; B Debanne; B Plaud; P Lasser
Journal:  Hepatogastroenterology       Date:  1998 Mar-Apr

8.  Management of retrohepatic inferior vena cava injury during hepatectomy for neoplasms.

Authors:  Li Ai-jun; Wu Meng-chao; Yang Guang-shun; Chen Han; Shen Fen
Journal:  World J Surg       Date:  2003-12-04       Impact factor: 3.352

9.  Hepatic resection with vascular isolation and routine supraceliac aortic clamping.

Authors:  M S Stephen; P J Gallagher; A G Sheil; D M Sheldon; D W Storey
Journal:  Am J Surg       Date:  1996-03       Impact factor: 2.565

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.